---
title: "Tech turmoil: Semiconductor stocks slide, healthcare finds footing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286934027.md"
description: "In today's trading, U.S. semiconductor stocks like Nvidia and AMD saw significant declines, while the healthcare sector, led by Eli Lilly and AbbVie, showed gains. The market sentiment is cautious due to concerns over the global chip shortage, but optimism in healthcare suggests a shift in investor interest. Recommendations include increasing healthcare allocations and considering semiconductor stocks for risk-tolerant investors, emphasizing the importance of diversification."
datetime: "2026-05-19T14:46:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286934027.md)
  - [en](https://longbridge.com/en/news/286934027.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286934027.md)
---

# Tech turmoil: Semiconductor stocks slide, healthcare finds footing

## Sector Overview

In today’s trading session, the U.S. stock market displayed _mixed signals_, with notable declines in the technology sector, particularly among semiconductor stocks. Companies such as Nvidia (NVDA) fell by 1.48%, while Advanced Micro Devices (AMD) faced a steep decline of 5.71%. Intel (INTC) also contributed to the downward trend with a drop of 4.06%. This downturn signals ongoing pressures in the semiconductor industry.

Conversely, the healthcare sector provided a beacon of stability, with major players like Eli Lilly (LLY) and AbbVie (ABBV) recording gains of 2.17% and 2.26%, respectively. This uptick was driven by robust earnings reports and positive clinical trial announcements.

### Market Mood and Trends

The overall market sentiment remains cautious as investors navigate a landscape marked by **volatility**. Concerns over the global chip shortage and its impact on tech manufacturing have heightened bearish outlooks within the semiconductor space. Conversely, the healthcare sector's gains suggest optimism around new drug approvals and other health innovations, redirecting some investor interest towards these traditionally defensive stocks.

### Strategic Recommendations

Given the **current market dynamics**, investors should consider increasing allocations in the healthcare sector, which continues to show resilience against broader market declines. Monitoring upcoming clinical developments and regulatory announcements will be vital for making informed decisions.

In contrast, while the technology sector, particularly semiconductors, experiences headwinds, this could present buying opportunities for risk-tolerant investors willing to hold through potential short-term fluctuations. As always, staying diversified across sectors is key to mitigating risk. Visit InvestingLive.com for real-time updates and detailed analyses.

### Related Stocks

- [AMD.US](https://longbridge.com/en/quote/AMD.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [NVDQ.US](https://longbridge.com/en/quote/NVDQ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [NVDD.US](https://longbridge.com/en/quote/NVDD.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [NVDU.US](https://longbridge.com/en/quote/NVDU.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [NVDL.US](https://longbridge.com/en/quote/NVDL.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SOXS.US](https://longbridge.com/en/quote/SOXS.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [AMDD.US](https://longbridge.com/en/quote/AMDD.US.md)
- [AMUU.US](https://longbridge.com/en/quote/AMUU.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [NVDS.US](https://longbridge.com/en/quote/NVDS.US.md)
- [AMDL.US](https://longbridge.com/en/quote/AMDL.US.md)
- [NVD.US](https://longbridge.com/en/quote/NVD.US.md)
- [NVDA.US](https://longbridge.com/en/quote/NVDA.US.md)
- [INTC.US](https://longbridge.com/en/quote/INTC.US.md)
- [NVD.DE](https://longbridge.com/en/quote/NVD.DE.md)

## Related News & Research

- [Eric Trump denial challenged by filings showing timed stock buys](https://longbridge.com/en/news/286953419.md)
- [Eli Lilly (LLY) Is Up 6.0% After Obesity Drug Data And $4.5B Manufacturing Push - Has The Bull Case Changed?](https://longbridge.com/en/news/286629257.md)
- [Trump purchased Eli Lilly stock as policies favored its drugs](https://longbridge.com/en/news/286791021.md)
- [Eli Lilly (LLY) Is the Face of the Obesity Boom. Has the Market Already Priced It In?](https://longbridge.com/en/news/286727957.md)
- [Eli Lilly delivers $50M boost to UNICEF’s pediatric health push](https://longbridge.com/en/news/286455712.md)